DiscoverDeviceTalks
DeviceTalks
Claim Ownership

DeviceTalks

Author: MassDevice

Subscribed: 31Played: 1,058
Share

Description

The DeviceTalks Podcast Network delivers news, insights and commentary from Medtech industry leaders. Our podcasts will inspire medtech professionals to create better medtech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 10 podcasts:

• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• DeviceTalks Weekly
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks
326 Episodes
Reverse
In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Powell, CEO and president of RefleXion, maker of a smart radiotherapy system used to combat cancer. Powell talks about his path into MedTech and how the company’s ScinTix system can “debulk” widespread cancer in patients. This episode is sponsored by the DeviceTalks West conference taking place Oct. 16-17 at the Santa Clara Convention Center. Register at West.DeviceTalks.com Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
In this episode of DeviceTalks AI, we explore the advancements in AI-driven technologies in women's health and cancer diagnostics. In our keynote interview, we speak with Michael Quick, Vice President of R&D and Innovation in Cytology & Oncology at Hologic. Quick shares his journey from a pre-med student to a leader in cytology innovation. He discusses the development and impact of Hologic’s Genius Digital Diagnostic Systems, the first FDA-approved digital cytology system, which leverages AI to enhance cervical cancer screening accuracy and efficiency. Michael emphasizes Hologic’s dedication to women's health and the critical role of AI in addressing the shortage of skilled cytologists, ensuring faster and more accurate diagnostics for patients worldwide. He also touches on the challenges and opportunities faced during the FDA approval process and the importance of early and collaborative engagement with regulatory bodies. We also hear from Dr. Wael Yared, Chief Technology Officer at Tecan, who highlights Tecan's contributions to cancer research and diagnostics. Dr. Yared elaborates on the company's innovations in liquid biopsy and solid tissue biopsy workflows, which leverage AI to streamline processes and reduce errors. He emphasizes the significance of partnerships in driving medical advancements and the role of AI in personalized medicine and multiomic capabilities. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about Tecan visit, https://partnering.tecan.com/ Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!
In this episode of Device Talks Weekly Podcast, Host Tom Salemi breaks down the recent Society of Robotic Surgery annual meeting with industry experts Steve Bell and Joe Mullings of The Mullings Group. The discussion ranges beyond the meeting into the state of Surgical Robotics. This episode is sponsored by DeviceTalks West. Go to West.DeviceTalks.com for more information. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi speaks with Dr. Janar Sathananthan, chief medical officer of Boston Scientific’s interventional cardiology therapies business about the coronary artery disease, stenting and its AGENT drug-coated balloon. This episode is sponsored by Freudenberg Medical. For more information, please visit www.freudenbergmedical.com. MassDevice’s Chris Newmarker and Sean Whooley join the Newmarker’s Newsmakers section to talk about the big MedTech story of the week as well as the news coming out of the American Diabetes Association annual meeting. Salemi also shares some thoughts from the Annual Meeting of the Society of Robotic Surgery. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.
In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle. Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.
In the latest episode of DeviceTalks AI, President and CEO of Asensus Surgical, Anthony Fernando walks us through the significant differences between augmented intelligence and artificial intelligence and how Asensus is leveraging these technologies to improve surgical outcomes. Anthony discusses the inception and evolution of Asensus Surgical's innovative robotic platforms, including the Senhance and Luna systems, and delves into the core advantages of using augmented over artificial intelligence to aid surgeons. He describes the Intelligent Surgical Unit (ISU), its unique regulatory pathway, and its pivotal role in providing the surgeon with real-time context, ensuring higher precision, consistency, and reduced cognitive fatigue during surgeries. To get the full story on the Karl Storz acquisition of Asensus Surgical, visit: https://www.massdevice.com/asensus-to-be-acquired-karl-storz/ In the second part of the episode, GM of Health AI at Amazon Web Services (AWS), Tehsin Syed, talks about the intersection of healthcare, life sciences, and AI and how AWS is helping healthcare and life sciences organizations leverage AI without the need for extensive technical expertise. Tehsin highlights AWS services like Comprehend Medical and HealthScribe, which are designed to simplify the processing and analysis of healthcare data. He also discusses the potential of generative AI in accelerating drug discovery, clinical trial optimization, and personalized medicine. Make sure to check out DeviceTalks Spotlight, a growing library of insights and expertise from the best in the medical device business: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4598161/devicetalks-spotlight Please subscribe to DeviceTalks AI on all major podcast channels and subscribe to DeviceTalks on YouTube to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!
In this week’s DeviceTalks Weekly Podcast, we dig deeper into the worlds of Corporate Venture Capital and Surgical Robotics. In our keynote interviews, Host Tom Salemi speaks with Abby Hunter-Syed, director of Olympus Innovation Ventures (OIV), the corporate arm of Olympus, the medical giant. Hunter-Syed explains how her own entrepreneurial experience led her to discover the joy of supporting start-ups. In this interview she explains why she favors open communication and how entrepreneurs can best approach OIV for capital. Before that conversation, we visit with Surgical Robotics Expert Steve Bell, an MedTech veteran who now advised start-ups. We preview the upcoming annual meeting of the Society of Surgical Robotics, which promises to unveil many interesting new surgical robotics systems. You can find out more about Steve Bell at www.howtostartupinmedtech.com. This episode is sponsored by DeviceTalks West. Registration opens next week. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.
In this episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi visits with Arun Menawat, CEO and Chairman of Profound Medical, developer of incision-free therapies which combine real-time MR imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. In the conversation we’ll discuss Menawat’s past successes and his vision for the future of surgery. Go to profoundmedical.com for more information. Thank you to Profound Medical for sponsoring this episode of the DeviceTalks Weekly podcast. We’re also thrilled to announce the return of the Newmarker’s Newsmakers! Chris Newmarker returns with a wrap up of the hottest news on MassDevice.com, the medical device industry’s leading news source. This week we’ll cover news from Microbot Medical, Stryker, BD, Edwards and others. If you want to hear Joe Mullings take on the Karl Storz/Asensus deal go here. https://www.devicetalks.com/can-sovato-health-build-digital-highway-for-remote-robotic-surgery-unpacking-the-storz-asensus-news/ Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.
In this episode of the DeviceTalks Weekly Podcast, we’ll talk with Gary Justak, president and general manager of Enovis’ foot & ankle business, about the rising war in the orthopedic extremities space. Co-hosts Tom Salemi and Chris Newmarker also host Jason Feipel, senior product development director of Medtronic’s Brain Modulation business, to find out details about the Percept RC DBS System. Andie Pequegnat, Director of Strategic Projects at Resonetics, teaches us more about nitinol. Resonetics sponsored this episode of the DeviceTalks Weekly Podcast and will host a DeviceTalks Tuesday discussion about nitinol later in June. Go to Resonetics.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Don’t miss a episode by subscribing to the DeviceTalks Podcast Network.
In this episode of the DeviceTalks Weekly Podcast, we’ll replay our Day 2 opening keynote at DeviceTalks Boston with three senior leaders from CMR Surgical, creator of the versatile Versius surgical robotic systems. Co-Founder Mark Slack, MD, now CMO, and Luke Hares, now CTO, identified several problems facing the healthcare system and explained why they saw surgical robotics as the solution. Longtime Medical Device Leader Supratim Bose, now CEO of the company, lends his insights in how Versius can fill a huge need for healthcare systems and hospitals. This episode is sponsored by Qt Group. Listen to understand how they can help your medical device development or go to Qt.io for more information. Thank you for listening to the DeviceTalks Weekly Podcast. You can subscribe to the DeviceTalks Podcast Network to listen to future episodes of this and our family of medical device podcasts. DeviceTalks.com
In this episode of DeviceTalks AI, we are joined by Ha Hong, PhD, Chief Artificial Intelligence Officer of Medtronic Endoscopy about integrating AI into Medtronic's endoscopy unit, the impact on healthcare outcomes, patient-centric design, and the future of AI in the medical device industry. Watch or listen to the episode to: - Discover how Ha's research coincided with the rise of deep learning, a pivotal technology in modern AI, and how it shaped his work in emulating visual perception processing in the brain. - Better understand Ha's instrumental role in developing the first FDA-approved AI-powered cardiac ultrasound guidance system, a groundbreaking innovation in cardiology. - Learn about Ha’s move to Medtronic and his vision for integrating AI into endoscopy, highlighting the potential for AI to revolutionize gastrointestinal diagnostics and treatment. - Gain insights into Ha's philosophy of patient-centric AI design, emphasizing the importance of prioritizing patient needs and safety in AI development for healthcare. In the episode, we also sit down with Joe Mish, VP of Sales at SmartTRAK to better understand how SmartTRAK is using AI to enhance their market intelligence solutions, combining the traditional robust analysis with advanced algorithms for more nuanced, speedier insights in the medtech industry. This conversation comes to you courtesy of our episode sponsor, SmartTRAK. To learn more about SmartTRAK, visit www.smarttrak.com. Please subscribe to DeviceTalks AI on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to DeviceTalks AI!
In this episode of DeviceTalks Weekly, we visit with Elizabeth McCombs, executive vice president and chief technology officer at BD. This is a replay of the opening keynote interview at DeviceTalks Boston. This conversation comes to you courtesy of our sponsor – MTD Micro Molding. Go to MTDMicromolding.com for more information or scan the QR code. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe now to the DeviceTalks Podcast Network.
In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business. Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com. Please subscribe to the DeviceTalks Podcast Network.
In this episode of AbbottTalks, Mahmood Kazemi, MD, Chief Medical Officer of Abbott’s Diabetes Care business overviews the profound advancements in diabetes management over the past decade and discusses the evolution of treatments and technological innovations that have revolutionized how individuals with diabetes approach their condition. Further, Dr. Kazemi underscores the benefits of advancements such as the GLP-1 receptor agonists and medications that control glucose levels and offer cardiovascular and renal protection. He then elaborates on how Abbott's FreeStyle Libre continuous glucose monitoring (CGM) systems have significantly improved diabetes management. These systems provide real-time data, empowering individuals to customize their medication, diet, and activity levels with unprecedented precision. He also speaks to Abbott's ongoing and future work, including developing a state-of-the-art continuous glucose ketone monitoring (CGKM) sensor. This medical biowearable is designed to provide crucial early warning signs in Type 1 diabetes management, a significant step towards preventing dangerous complications and hospitalizations. Looking to the future, Kazemi anticipates a wider adoption of CGM across the diabetes community, including those with type 2 diabetes, and an increase in insurer coverage. Thank you to BMP Medical for sponsoring this episode of AbbottTalks! For more information on how BMP Medical works with medical device companies, visit www.bmpmedical.com Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.
In this week’s episode of the DeviceTalks Weekly Podcast, Editorial Director Tom Salemi talks about next week’s DeviceTalks Boston meeting with MedTech Innovator CEO Paul Grand. We also hear interviews done earlier this year with speakers – Bertin Nahum of Quantum Surgical, Kurt Haggstrom of Synchron and Closing Keynote Speaker Rajit Kamal of Medtronic. Anyone interested attending – and meeting a surprise surgical robotics guest – can register at Boston.DeviceTalks.com. Use the code DTWeekly25 to save 25% of the registration fee. Thanks for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.
In the final episode of MedtechWOMEN Talks season one, we are joined by YJ Oh, SVP US Sales, Marketing and Commercial Operations at Edwards Lifesciences, who takes us through the intricate process of medical device commercialization. Starting with her unique entry into the medtech industry, YJ shares her comprehensive journey from sales to global marketing, emphasizing the significant role of upstream marketing in shaping product development and downstream efforts in executing commercial strategies. In the discussion, YJ highlights the criticality of understanding market needs right from the inception of a product idea, ensuring that every development phase aligns with customer insights and real-world applicability. She provides a glimpse into the key collaborations across various departments and touches on the essential feedback mechanisms in place, ensuring devices meet the stringent requirements and expectations set forth by both regulatory bodies and the end-users, primarily physicians. Her insights extend into the strategic considerations for global market penetration, discussing how different regulatory landscapes affect the accessibility and success of medical devices across borders. TL;DR – Key Takeaways: - The integration of market insights from the beginning is crucial for successful medical device commercialization. - Collaborative efforts across various functions are vital to address the comprehensive demands of product development. - Strategic global considerations are imperative to navigate varying regulatory and market conditions effectively. Thank you to our season one sponsors Aptyx, Catalyze Healthcare, Confluent Medical Technologies, and Cretex Medical! https://aptyx.com/ https://catalyzehealthcare.com/ https://confluentmedical.com/ https://www.cretex.com/ Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode. Thank you for listening to MedtechWOMEN Talks!
In this episode, we visit with Rebecca Seidel, president of Medtronic’s cardiac ablation solutions group, about the future of pulsed-field ablation and what it means for the electrophysiology sector. Host Tom Salemi also visits with biomedical researcher Jeff Karp to discuss his new book, LIT: Life Ignition Tools: Use Nature's Playbook to Energize Your Brain, Spark Ideas, and Ignite Action Kindle Edition. Use the code LIT25 to save 25% off the registration price of DeviceTalks Boston and you could win a free copy. Karp will also be at DeviceTalks Boston’s opening reception on April 30. Come meet the author and noted medtech innovator. Finally, we get a #DTBoston2024 speaker preview – Scott Nelson, CEO of FastWave Medical, one of two IVL companies we’ll have at the conference! Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network
In this episode of StrykerTalks, Spencer Stiles, Group President of Orthopaedics and Spine at Stryker, discusses Stryker's latest advancements shaping the future of orthopedics and spine care, including an update on the significant role of Mako, Stryker’s pioneering robotic arm-assisted system. Additionally, Stiles discusses the expansive reach of these innovations, emphasizing their rapid adoption across global markets, particularly in Asia, where Stryker’s advanced solutions meet diverse clinical needs and operational settings. He shares insights into how these technologies cater to the unique challenges faced in different regions, enhancing Stryker's impact on global healthcare landscapes. The conversation further explores Stryker’s strategic growth initiatives, particularly its approach to mergers and acquisitions. Stiles outlines how these moves are carefully crafted to align with Stryker’s long-term vision, ensuring that each acquisition not only expands their market presence but also complements their existing portfolio. Thank you to DornerWorks for sponsoring this episode. To learn more about how DornerWorks supports medical device companies, visit www.DornerWorks.com. Thank you for listening to the StrykerTalks Podcast. Subscribe to the DeviceTalks Podcast Network on every major podcast platform.
In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives! Thanks for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network.
In this week’s DeviceTalks Weekly podcast episode, Host Tom Salemi talks with Joe Mullings of The Mullings Group about the Karl Storz and Asensus Surgical News as well as Johnson & Johnson's big play for Shockwave Medical. Then, we talk with the leaders of Sovato Health - Yulun Wang, PhD, chairman & co-founder, and Cynthia Perazzo, Co-founder and CEO, about the startup’s plans to build a fiberoptic network to enable remote robotic surgery procedures. Thank you for listening to the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network to catch future episodes.
loading
Comments